Senti Biosciences Gets Bullish Analyst Coverage with 614% Upside Potential
H.C. Wainwright initiates Senti Bio with Buy rating and $12 target. Cancer therapy developer's CAR-NK platform shows promise for blood cancers and solid tumors.
NOTRELOAD AI
General Motors Takes $1.6 Billion Charge to Right-Size EV Capacity
GM booked a $1.6B charge, reducing its EV production plans. Demand is slower than expected due to gov't ending tax credits and changing rules.
BioCryst to Acquire Astria Therapeutics in $700M Deal to Boost Rare Disease Portfolio
BioCryst Pharmaceuticals announces $700M acquisition of Astria Therapeutics, adding promising hereditary angioedema drug to expand rare disease treatment options.
Dealmaking Resurgence and Asset Growth Drive Goldman Sachs to Record Revenue Haul
Goldman Sachs profit jumped 37% on record sales. Huge fees from company dealmaking and growing client assets drove the big quarterly win.
Domino's Beats the Odds: Promotions and Value Deals Drive Strong U.S. Same-Store Sales Growth in Q3
Domino's beat profit and U.S. sales estimates. Success came from deals (like the revived "$9.99 Best Deal Ever") and new menu items. Customers are seeking value due to inflation. International sales missed targets.
Wells Fargo Raises Profit Target After Breaking Free from Regulatory Chains
Wells Fargo increases profitability goal to 17-18% ROTCE after Fed removes asset cap. Q3 results show growth in investment banking and noninterest income despite slight NII miss.